Els De Haese
About Els De Haese
Els De Haese is the Associate Director of PV & Audits, PV & Lifecycle Management Qual at Bristol Myers Squibb in the Flemish Region, Belgium, with over 24 years of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Els De Haese is currently an Associate Director in the PV & Audits, PV & Lifecycle Management Quality department at Bristol Myers Squibb. She is located in the Flemish Region, Belgium. Her role focuses on overseeing pharmacovigilance audits and managing the lifecycle quality of various pharmaceutical products.
Past Experience at Bristol Myers Squibb
Before her current role, Els De Haese served as a Senior Manager in Regulatory Affairs, PV & Lifecycle Management Quality at Bristol Myers Squibb from 2020 to 2021. During her tenure, she applied her extensive regulatory knowledge to ensure compliance and manage quality standards effectively.
Career at Servier
Els De Haese has a long-standing history with Servier, where she worked for over two decades. Her roles ranged from a Clinical Research Associate between 1997 to 1999, to Quality Assurance Manager from 1999 to 2020, and eventually to Pharmacovigilance Auditor and Global R&D QA Auditor until 2020. Her responsibilities included overseeing clinical trials, ensuring quality standards, and conducting global R&D audits, working in both Belgium and France.
Industry Experience
With over 24 years of experience in the pharmaceutical industry, Els De Haese has a robust background in quality assurance and pharmacovigilance. She has held various key positions that required in-depth knowledge of regulatory affairs and compliance. Her professional journey has provided her with a thorough understanding of international regulatory standards.
Expertise in Regulatory Affairs
Throughout her career, Els De Haese has demonstrated significant expertise in regulatory affairs. She has held senior managerial positions in this field, particularly at Bristol Myers Squibb, where she managed regulatory compliance and quality assurance processes. Her experience ensures she is adept at maintaining high standards required in the pharmaceutical industry.